Journal of Clinical Investigation · 2000 · 168 citations · 31 references
MedicineHematologyPharmacologyHematology PhysiologyHematopathologyRenal PathophysiologyAnemiaAnemia Of Chronic DiseaseAngiogenesisHematocrit RegulationRed Blood Cell PhysiologyRenal HemodynamicsAngiotensin-converting Enzyme Inhibitor ManagementErythropoietin RegulationRed Blood Cell Mass RegulationRenal Function LossRenin-angiotensin System BlockadeRenin-angiotensin System InhibitorsSuppressor Cell Biology
While nephrologists often observe reduced hematocrit associated with inhibitors of angiotensin-converting enzyme (ACE), the basis for this effect is not well understood. We now report that two strains of ACE knockout mice have a normocytic anemia associated with elevated plasma erythropoietin levels. (51)Cr labeling of red cells showed that the knockout mice have a normal total blood volume but a reduced red cell mass. ACE knockout mice, which lack tissue ACE, are anemic despite having normal renal function. These mice have increased plasma levels of the peptide acetyl-SDKP, a possible stem cell suppressor. However, they also show low plasma levels of angiotensin II. Infusion of angiotensin II for 2 weeks increased hematocrit to near normal levels. These data suggest that angiotensin II facilitates erythropoiesis, a conclusion with implications for the management of chronically ill patients on inhibitors of the renin-angiotensin system.
31
Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors
Evan Parganas, Demin Wang, Dimitrios J. Stravopodis et al. · Cell · 1998 · 1.2K citations · Full text
Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis
Hans Neubauer, Ana Cumano, Mathias Müller et al. · Cell · 1998 · 915 citations · Full text
Biology of the Laboratory Mouse
JAMA · 1941 · 807 citations
Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
Mario B. Marrero, Bernhard Schieffer, William G. Paxton et al. · Nature · 1995 · 745 citations